MedMira(TSXV) MIR

Current PriceCA$0.07

Market CapCA$49.12M

Since IPO (2000)-99%

5 Year-48%

1 Year-7%

1 Month+0%

MedMira last closing stock price
Metric	Price	Date
Last close	CAD 0.07	2026-07-23

MedMira stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	CAD 0.07	2026-07-16
1 month	+0%	CAD 0.07	2026-06-23
3 month	+8.33%	CAD 0.06	2026-04-23
Year to date	+0%	CAD 0.07	2025-12-31
1 year	-7.14%	CAD 0.07	2025-07-23
3 year	-23.53%	CAD 0.09	2023-07-24
5 year	-48%	CAD 0.13	2021-07-23
Since inception	-99.33%	CAD 10.50	2000-03-15

MedMira Financials at a Glance

Market Cap

CA$49.12M

Revenue (TTM)

CA$370.57K

Net Income (TTM)

-CA$2.99M

EPS (TTM)

-CA$0.00

P/E Ratio

-16.28

Dividend

CA$0.00

Beta (Volatility)

0.55 (Low)

Dividend

CA$0.00

Beta (Volatility)

0.55 (Low)

Price

CA$0.07

Volume

5,162

Open

CA$0.07

Price

CA$0.07

Volume

5,162

Open

CA$0.07

Previous Close

CA$0.07

Daily Range

CA$0.07 - CA$0.07

52-Week Range

CA$0.05 - CA$0.11

Estimated Earnings Date

Jun 30, 2026

Dividend

CA$0.00

Beta (Volatility)

0.55 (Low)

Price

CA$0.07

Volume

5,162

Open

CA$0.07

Previous Close

CA$0.07

Daily Range

CA$0.07 - CA$0.07

52-Week Range

CA$0.05 - CA$0.11

Estimated Earnings Date

Jun 30, 2026

MIR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MedMira

MedMira Inc. is a biotechnology company dedicated to the research, development, manufacturing, and global commercialization of rapid diagnostic solutions. With a diverse portfolio of products, MedMira serves various segments of the healthcare industry across multiple international markets.

Products and Services

Reveal HIV tests for HIV-1 and HIV-2 antibodies
Multiplo line for combined screening of multiple conditions
VYRA CoV2 for SARS-CoV-2 antigen detection

Growth Outlook

Expansion into new international markets is underway
Increased demand for rapid diagnostics post-pandemic
Focus on innovative product development to enhance market position

Financial Highlights

Recent quarterly revenue of CAD 241,189, showing potential for growth
Trailing twelve months (TTM) revenue of CAD 1,000,000, indicating steady performance
Operating expenses remain high, reflecting ongoing investment in R&D

MedMira Inc. operates in a rapidly evolving biotechnology sector, focusing on innovative diagnostic solutions that address critical healthcare needs. The company's diverse product offerings, including tests for HIV, syphilis, and COVID-19, position it well to capitalize on the growing demand for rapid diagnostics. Recent financial data indicates a revenue of CAD 241,189 for the latest quarter, with a TTM revenue of CAD 1,000,000, suggesting a stable revenue stream. However, the company continues to face high operating expenses, primarily due to significant investments in research and development. This strategic focus on innovation and market expansion may enhance MedMira's competitive edge in the biotechnology industry.

AI Generated • Jul 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Hermes Hermes Chan

Website

www.medmira.com

Headquarters

Halifax, NS B3S 1B3, CA

MIR Financials

Key Financial Metrics (TTM)

Gross Margin

-448.07%

Operating Margin

-473.40%

Net Income Margin

-808.18%

Return on Equity

12.68%

Return on Capital

N/A

Return on Assets

-88.07%

Earnings Yield

-6.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$49.12M

Shares Outstanding

701.73M

Volume

5.16K

Avg. Volume

70.91K

Financials (TTM)

Gross Profit

-CA$1.66M

Operating Income

-CA$1.75M

EBITDA

-CA$1.75M

Operating Cash Flow

-CA$1.19M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.19M

Cash & ST Invst.

CA$0.00

Total Debt

CA$17.42M

MedMira Performance Analysis

MedMira annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-07-31	CAD 952,127	-55.6%
2023	2023-07-31	CAD 432,529	-54.6%
2024	2024-07-31	CAD 412,568	-4.6%
2025	2025-07-31	CAD 240,509	-41.7%

MedMira sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-07-31	-14.3%
Q1	2025-10-31	7.0%
Q2	2026-01-31	-54.8%
Q3	2026-04-30	884.3%

MedMira annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-07-31	CAD -0.00	170.0%
2023	2023-07-31	CAD -0.00	40.7%
2024	2024-07-31	CAD -0.00	26.3%
2025	2025-07-31	CAD -0.01	35.4%

MedMira sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2025-07-31	-7.1%
Q1	2025-10-31	20.0%
Q2	2026-01-31	16.7%
Q3	2026-04-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

CA$241.19K

+308.0%

Gross Profit

-CA$64.26K

-249.4%

Gross Margin

-26.64%

N/A

Market Cap

CA$49.12M

N/A

Market Cap/Employee

CA$944.64K

N/A

Employees

N/A

Net Income

-CA$483.66K

+50.8%

EBITDA

-CA$187.05K

+71.2%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Total Cash

CA$0.00

-100.0%

Total Debt

CA$17.42M

+71.4%

Accounts Receivable

CA$1.30M

-1.1%

Inventory

CA$191.75K

-14.8%

Long Term Debt

CA$2.52M

-29.8%

Short Term Debt

CA$14.90M

+126.7%

Return on Assets

-88.07%

N/A

Return on Invested Capital

7.98%

N/A

Free Cash Flow

-CA$150.63K

+83.6%

Operating Cash Flow

-CA$150.63K

+83.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SVA.TOSernova Corp.

SVA.TOSernova Corp.CA$0.12+0.00%

COV.VCovalon Technologies Ltd.

COV.VCovalon Technologies Ltd.CA$2.18+3.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.76-0.29%

NOKNokia

NOKNokia$9.73-0.05%

INTCIntel

INTCIntel$100.23-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.56-0.08%

TAT&T

TAT&T$22.96-0.00%

SMCISuper Micro Computer

SMCISuper Micro Computer$31.20+0.02%

ONDSOndas

ONDSOndas$7.93-0.01%

Questions About MIR

What is the current price of MedMira?

MedMira is trading at CA$0.07 per share.

What is the 52-week range for MedMira?

Over the past 52 weeks, MedMira has traded between CA$0.05 and CA$0.11.

How much debt does MedMira have?

As of the most recent reporting period, MedMira reported total debt of CA$17.42M.

How much cash does MedMira have on hand?

MedMira reported CA$0.00 in cash and cash equivalents in its most recent financial results.

What is MedMira’s dividend yield?

MedMira does not currently have a dividend yield.

MedMira(TSXV) MIR

MedMira Financials at a Glance

MIR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About MedMira

MIR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

MedMira Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MIR

What is the current price of MedMira?

What is the 52-week range for MedMira?

How much debt does MedMira have?

How much cash does MedMira have on hand?

What is MedMira’s dividend yield?

Premium Investing Services